About
Incorporated in September 2012, Standard Glass Lining Technology Limited manufactures engineering equipment for the pharmaceutical and chemical sectors. The company provides turnkey solutions, including design, engineering, manufacturing, assembly, installation, and standard operating procedures. Its product portfolio includes Reaction Systems, Storage, Separation, and Drying Systems, and Plant Engineering. The company operates eight manufacturing units in Hyderabad and has sales offices in various locations across India. Notable clients include Aurobindo Pharma, Cadila Pharmaceuticals, and Laurus Labs.
Issue size
Funds to be Raised in the IPO |
Amount |
Overall |
₹410.05 crores |
Fresh Issue |
₹210.00 crores |
Offer for sale |
₹200.05 crores |
The utilisation of proceeds:
Purpose |
INR crores (%) |
Capital expenditure for machinery and equipment |
10.00 (4.76%) |
Repayment of borrowings and investment in subsidiary |
130.00 (61.90%) |
Investment in a subsidiary for capital expenditure |
30.00 (14.29%) |
Inorganic growth through acquisitions |
20.00 (9.52%) |
Financial Snapshot
Financial Year Ended |
March 2022 |
March 2023 |
March 2024 |
September 2024 |
Total Assets |
298.11 |
347.78 |
665.38 |
756.52 |
Revenue |
241.50 |
500.08 |
549.68 |
312.10 |
Profit After Tax |
25.15 |
53.42 |
60.01 |
36.27 |
*All figures are in ₹ Crores.
Strengths
- Top five specialized engineering equipment manufacturers for the pharmaceutical and chemical sectors in India, with full in-house capabilities.
- Leading manufacturer of glass-lined, stainless steel, and nickel alloy-based equipment in India.
- Custom solutions for pharmaceutical, chemical, food, and beverage industries.
- Supplied over 11,000 products in the last decade, meeting diverse sector needs.
- In-house manufacturing of stainless steel glass-lined reactors, up to 10KL capacity.
- Active partnerships with HHV Pumps and GL Hakko to strengthen product offerings and market position.
- Equipped with cutting-edge CNC plasma, laser cutting, and welding systems.
Risk factors
- The company has provided guarantees for subsidiary loans, and any default may result in additional expenses, affecting profitability.
- Heavy dependence on pharmaceutical and chemical sectors.
- Risks from under-utilization of manufacturing capacity.
- Vulnerability to delays or defaults in customer payments.
- Exposure to raw material cost fluctuations.
- Limited ability to pass on raw material cost increases.
- Dependence on Telangana facilities, subject to risks from disasters and political changes.
IPO Schedule
Issue Period |
6th January to 08th January 2025 |
Price band |
₹ 133 - 140 |
Minimum Bid quantity |
107 shares |
UPI Mandate Deadline |
5 PM, 08 January 2025 |
Allotment Finalization |
09 January 2025 |
Refund Initiation |
10 January 2025 |
Share Credit |
10 January 2025 |
Listing Date |
13 January 2025 |
Mandate end date |
23 January 2025 |
Lock-In End Date for Anchor Investors (50%) |
08 February 2025 |
Lock-In End Date for Anchor Investors (Remaining) |
09 April 2025 |
Allotment Status for Standard Glass Lining Technology Limited IPO
To check your allotment status - click here.
2 Likes